Platelets regulate leucocyte responses to Toll-like receptor stimulation

Objectives. Platelets are important regulators of vascular thrombosis and inflammation and are known to express Toll-like receptors (TLRs). Through TLRs, platelets mediate a number of responses by interacting with leucocytes. Here, we report the extent to which platelets modulate in vitro peripheral blood mononuclear cells (PBMCs) and granulocyte responses to TLR4, TLR2/1 and TLR2/6 stimulation in healthy subjects. Methods. Peripheral blood mononuclear cells and granulocytes from 10 healthy volunteers were cultured alone or cocultured with platelets. Cultures were left unstimulated or stimulated with 1 or 100 ng mL(-1) of either LPS (TLR4 agonist), Pam3CSK4 (TLR2/1 agonist) or fibroblast-stimulating lipopeptide (FSL)-1 (TLR2/6 agonist). Neutrophil activation (CD66b expression), monocyte activation (HLA-DR), granulocyte elastase production and PBMC cytokine and chemokine production were examined. Results. Platelet coculture decreased neutrophil CD66b expression in response to LPS, Pam3CSK4 and FSL-1, and modestly decreased monocyte HLA-DR expression in response to low-dose LPS. Platelets reduced granulocyte elastase secretion in response to low doses of all TLR agonists tested. In response to LPS, platelet coculture reduced IL-6, tumor necrosis factor (TNF)-alpha and MIP-1 beta production, and increased IL-10 production by PBMCs. In response to FSL-1, platelets increased IL-6, IL-10 and MIP-1 beta production, but reduced TNF-alpha production. Platelet coculture did not alter PBMC cytokine/chemokine production in response to Pam3CSK4. Conclusion. This study challenges the notion that platelets act solely in a pro-inflammatory manner. Rather, platelets are complex immunomodulators that regulate leucocyte responses to TLR stimulation in a TLR agonist-specific manner. Platelets may modulate leucocyte responses to dampen inflammation, and this platelet effect may play an important role in reducing inflammation-mediated host damage.